Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 4/20 | 1.00 |
| ▸ | NOS2 | P35228 | 9/20 | 0.75 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.75 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.74 |
| ▸ | USP7 | Q93009 | 2/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | STAT3 | P40763 | 1/20 | 0.74 |
| ▸ | CCR6 | P51684 | 1/20 | 0.65 |
| ▸ | RORC | P51449 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19635897 | 1.00 | MBOAT4 (1.00) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL15469127 | 1.00 | MBOAT4 (1.00) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL10078968 | 1.00 | MBOAT4 (1.00) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL18682368 | 0.93 | MBOAT4 (0.88) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL18682396 | 0.93 | MBOAT4 (0.88) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL18682607 | 0.93 | MBOAT4 (0.88) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL18682612 | 0.93 | MBOAT4 (0.88) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL20983761 | 0.92 | MBOAT4 (0.85) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL21022372 | 0.92 | MBOAT4 (0.85) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL18682395 | 0.92 | MBOAT4 (0.85) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353190-B1 | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES | REATA PHARMACEUTICALS INC (US) | 2021-03-17 | — | — | EP | disclosed |
| WO-2011130302-A2 | METHOD OF TREATING OBESITY USING ANTIOXIDANT INFLAMMATION MODULATORS | REATA PHARMACEUTICALS, INC. (US) | 2011-10-20 | — | — | WO | disclosed |
| WO-2010053817-A1 | BETULINIC ACID DERIVATIVES AND METHODS OF USE THEREOF | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2010-05-14 | — | — | WO | disclosed |
| WO-2009129546-A1 | ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17 | REATA PHARMACEUTICALS, INC. (US) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009089545-A1 | SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE | REATA PHARMACEUTICALS, INC. (US) | 2009-07-16 | — | — | WO | disclosed |